Mutual Fund Ownership
Ownership as on: Wed, 24 Apr, 2024

Quant Multi Asset Fund Growth

NA
Hybrid
Amount Invested (Cr.)131.93
% of AUM7.21%

Quant Value Fund Regular Growth

NA
Equity
Amount Invested (Cr.)69.85
% of AUM5.44%

JM Focused Fund - Growth Option

2/5
Equity
Amount Invested (Cr.)2.98
% of AUM3.35%

Tata India Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)18.29
% of AUM2.08%

JM Aggressive Hybrid Fund Growth

4/5
Hybrid
Amount Invested (Cr.)4.18
% of AUM1.88%

FAQs about Orchid Pharma share price

Orchid Pharma is trading at 1069.95 as on Wed Apr 24 2024 09:59:47. This is 1.06% upper as compared to its previous closing price of 1058.75.

The market capitalization of Orchid Pharma is 5426.69 Cr as on Wed Apr 24 2024 09:59:47.

The average broker rating on Orchid Pharma is Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Orchid Pharma is 1358.80 whereas the 52 wk low is 371.20

Orchid Pharma can be analyzed on the following key metrics -

  • TTM P/E: 25.00
  • Sector P/E: 27.48
  • Dividend Yield: 0.00%
  • D/E ratio: -

Orchid Pharma reported a net profit of 46.32 Cr in 2023.

Recommended For You
Trending Stocks
165.50+4.40(2.73%)
1,843.05+29.80(1.64%)
1,186.10-14.00 (-1.17%)
HomeMarketsPremiumFor youGet App